cupure logo
2025charlieworkerspaykirkyearcharlie kirkrisesbankshooting

AstraZeneca pauses £200m investment in Cambridge research site

Decision means none of drugmaker’s much-trumpeted £650m UK investment package is currently proceedingThe drugmaker AstraZeneca has paused a planned £200m expansion of its Cambridge research site, completing a depressing week for the UK pharmaceutical industry.The decision by the UK’s largest company means none of its much-trumpeted £650m investment package in the UK – which was originally announced in March 2024 – is proceeding. Continue reading...

Comments

Business News